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Abstract: Background: Patients with cancer receiving tumor therapy often suffer from oral mucositis.
Objectives: The aim of this project was to summarize experiences with nursing procedures by experts in
integrative oncology and to establish recommendations for nursing interventions that can prevent or cure
mucositis. Methods: The study design was an interdisciplinary consensus process based on a systematic
literature search. Results: The panel discussed and agreed on 19 nursing procedures, which included
mouthwashes, such as teas, supplements, oil applications, and different kinds of ice cubes to suck, as
well as flaxseed solution, propolis, and mare milk. Twelve interventions were classified as effective, with
effectiveness for OraLife, propolis, sea buckthorn pulp oil, marshmallow root tea also for xerostomia,
Helago chamomile oil, mare milk, and Saliva Natura rated as highly effective in clinical experience. In
the systematic literature search, a total of 12 out of 329 randomized controlled trials and meta-analyses
on chamomile (n = 3), Calendula (n = 1) and sage (n = 1), propolis (n = 2), and sucking ice cubes
(cryotherapy; n = 5) met all inclusion criteria. Trial evidence for effectiveness in oral mucositis was
revealed for propolis and cryotherapy. Conclusions: The current evidence supports the use of some
nursing procedures (f.e. propolis for 2 and 3 grade mucositis) for improving oral mucositis during cancer
therapies. There is still a need to define general clinical practice guidelines for the supportive treatment
of mucositis, as well as for more interdisciplinary research in this area.
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Abstract
Background: Patients with cancer receiving tumor therapy often suffer from oral mucositis. Objectives: The aim of 
this project was to summarize experiences with nursing procedures by experts in integrative oncology and to establish 
recommendations for nursing interventions that can prevent or cure mucositis. Methods: The study design was an 
interdisciplinary consensus process based on a systematic literature search. Results: The panel discussed and agreed on 
19 nursing procedures, which included mouthwashes, such as teas, supplements, oil applications, and different kinds of ice 
cubes to suck, as well as flaxseed solution, propolis, and mare milk. Twelve interventions were classified as effective, with 
effectiveness for OraLife, propolis, sea buckthorn pulp oil, marshmallow root tea also for xerostomia, Helago chamomile 
oil, mare milk, and Saliva Natura rated as highly effective in clinical experience. In the systematic literature search, a 
total of 12 out of 329 randomized controlled trials and meta-analyses on chamomile (n = 3), Calendula (n = 1) and sage 
(n = 1), propolis (n = 2), and sucking ice cubes (cryotherapy; n = 5) met all inclusion criteria. Trial evidence for effectiveness 
in oral mucositis was revealed for propolis and cryotherapy. Conclusions: The current evidence supports the use of 
some nursing procedures (f.e. propolis for 2 and 3 grade mucositis) for improving oral mucositis during cancer therapies. 
There is still a need to define general clinical practice guidelines for the supportive treatment of mucositis, as well as for 
more interdisciplinary research in this area.
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Introduction
Cancer therapies, such as radiotherapy (RT) of the head and 
neck, various chemotherapies (CT) or hematopoietic stem 
cell transplantation (HSCT), often cause oral mucositis.1 
This condition leads to oral pain, significant dysphagia 
resulting in weight loss, decreased quality of life, and ther-
apy discontinuation. Ulcerative lesions can also be second-
arily infected and potentially lead to systemic sepsis in 
immune compromised patients.1 Oral mucositis affects over 
75% of high-risk patients,2 and thus needs to be urgently 
addressed in treatment and care for both inpatients and out-
patients. In particular, the use of an integrative oncology 
approach in the prevention and treatment of oral mucositis 
seems promising. Integrative oncology is defined as
a patient-centered, evidence-informed field of cancer care that 
utilizes mind and body practices, natural products, and/or 
lifestyle modifications from different traditions alongside 
conventional cancer treatments. Integrative oncology approach 
aims to optimize health, quality of life, and clinical outcomes 
across the cancer care continuum and to empower people to 
prevent cancer and become active participants before, during, 
and beyond cancer treatment.3
Integrative oncology approach requires a multidisci-
plinary team work including all necessary health profession-
als such as physicians, nurses, and psychologists.3 Especially 
nurses play a key role in the care of oral mucositis within 
this team. According to our own clinical experiences, nurses 
in German-speaking hospitals with naturopathic and/or 
anthroposophic medicine backgrounds often use various 
applications to prevent or improve mucositis in supportive 
care for cancer patients.1,4 Therefore, we first needed to 
identify which integrative oncology strategies different hos-
pitals regularly apply for the prevention or therapy of radio- 
or chemotherapy-associated mucositis, how these methods 
are integrated and applied, and whether they are effective 
and safe. Because of the lack of standardization and differ-
ences in levels of evidence in clinical management of oral 
mucositis, research is needed in this area.5-7 There are lim-
ited studies based on consensus processes in the literature in 
this purpose. The aim of the guideline was to define stan-
dards for commonly used integrative oncology approaches 




This guideline is based on an interdisciplinary consensus 
process followed by a systematic literature search. First, we 
conducted an integrative oncology nursing expert consen-
sus to identify commonly used supportive treatment strate-
gies for mucositis, as well as their perceived efficacy and 
safety in clinical practice. After expert consensus assess-
ment, a systematic literature search of the identified inter-
ventions was conducted.
Consensus Process
We conducted a symposium on nursing in integrative oncol-
ogy in Essen, Germany, in September 2017. We invited uni-
versity hospitals and hospitals with expertise in integrative 
oncology nursing procedures, who also do research in the 
field of integrative oncology. Additionally, we invited nurses 
with a high clinical expertise who train nurses in the field of 
integrative oncology nursing procedures. Experts (nurses, 
physicians, psychologist) in the field of integrative oncology 
participated from 6 different institutions in German-speaking 
countries: Evang. Kliniken Essen-Mitte (academic teaching 
hospital), Medizinische Hochschule Hannover (University 
hospital), Filderklinik (nonprofit, anthroposophic hospital), 
Kantonsspital St. Gallen (Comprehensive Cancer Centre), 
Robert-Bosch-Krankenhaus (academic teaching hospital), 
CONGO trial group with StädtischesKlinikum Karlsruhe 
(academic teaching hospital), Universitätsklinikum Tübingen 
(University hospital), and Universitätsklinikum Heidelberg 
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(University hospital). This interdisciplinary expert group rep-
resented institutes using integrative oncology approaches in 
clinical practice. To ensure an adequate diversity in expertise, 
nurses, physicians, and one psychologist with experience in 
the field of integrative oncology were brought together. The 
symposium’s purpose was to develop clinical and research 
recommendations for supportive treatment of mucositis, 
which are commonly used in clinical practice through a con-
sensus procedure.
In the first round of the consensus process, all nursing 
procedures for mucositis were collected and discussed by 
the experts with regard to application and experience with 
this indication. A total of 19 treatments were evaluated by 
the expert panel. In a second round, every application was 
evaluated within the expert panel for safety (rated S = 
safe or nS = not safe), effectiveness based on clinical 
experience (CE; rated on a 6-point Likert-type scale from 
CE 0 to CE 5, with CE 0 = no effect in clinical experience 
and CE 5 = maximum effect in clinical experience), 
patient education (rated PE 0 = patient education is not 
necessary or PE 1 = patient education is necessary), and 
practical feasibility (rated PF = feasibility not limited, PFt 
= feasibility limited due to time requirements [more than 
15 minutes], or PFc = feasibility limited due to high 
costs). The financial effort was classified as high when 
therapy costs exceeded 30€ per month. For consensus, 
each of the 6 institutions held 1 vote per nursing applica-
tion only when this method was commonly used in their 
institution. It was further decided by usual care, practica-
bility, cost, and similar factors whether the method was 
generally applicable in prevention and/or therapy and/or 
whether its use was limited to immune-suppressed 
patients, for example, HSCT.
Literature Search Process
In the literature search, we investigated all 19 treatments dis-
cussed in the consensus process. The identified frequently 
used approaches in the prevention or treatment of oral muco-
sitis were then evaluated based on a systematic literature 
search in PubMed, the Cochrane Central Register of 
Controlled Trials (CENTRAL), EMBASE as well as in spe-
cialized complementary medicine databases including the 
CAM summaries, the German version of Onkopedia, and 
Memorial Sloan Kettering Cancer Center (MSKCC) “About 
Herbs” database. For PubMed, the complete search strategy 
was “mucositis or stomatitis” and “cancer” and “(chamomile 
or Kamistad or Salvia or Repha-Os or Saliva Natura or 
marshmallow root or flaxseed or propolis or oil extraction or 
almond oil or cryotherapy or tea or Traumeel or OraLife or 
mare milk)” (Table 2; see supplementary file, available 
online). The search strategy was adapted for the other data-
bases as appropriate. Additionally, national and international 
medical guidelines (AWMF, MASCC) were screened from 
web pages of Multinational Association of Supportive Care 
in Cancer1 and Leitlinienprogramm Onkologie4 by manual 
search. The last search date was November 6, 2019. The 
review was not registered prospectively.
The inclusion criteria were the following: (1) partici-
pants were adult cancer patients of any gender or ethnicity, 
any type of cancers, and any type of cancer treatments (RT, 
CT, HSCT); the study design was randomized controlled 
trial (RCT), meta-analysis, or medical guideline; (2) out-
comes included oral mucositis or stomatitis measurements; 
and (3) studies were published in English language. Only 
those treatments that were evaluated by expert panel in the 
consensus process were included in the literature search. 
The study data were extracted by 2 authors (DS, BBS) inde-
pendently using a standard data extraction approach that 
included data on study methodology, participants, interven-
tions, comparisons, outcomes, and conclusions. The evi-
dence level of the studies that met the inclusion criteria 
were evaluated using the Oxford Centre for Evidence-based 
Medicine (OCEBM).8
Results
Results of the Consensus Process
Participants were mostly female (93.8%) and nurses 
(68.8%) or physicians (25.0%) with naturopathic and/or 
anthroposophical medicine backgrounds. In the setting of a 
2-day symposium, the 16 expert participants from 6 differ-
ent institutions in the field of integrative oncology gathered 
19 nursing procedures that could be administered to pre-
vent or treat oral mucositis. Table 1 lists the different inter-
ventions and indications and shows the results of the expert 
panel according to safety (also in immune-suppressed 
patients), effort of training, practical feasibility, and clini-
cal experience. Table 2 shows the active ingredients of 
medical agents (OraLife, Saliva Natura, Kamistad STADA, 
RephaOs, Traumeel).
The expert panel established basic safety advice for all 
nursing procedures: high-quality products should be used, 
and allergies or a version of taste or smell need to be consid-
ered. For teas, it was recommended to use a pharmaceutical 
quality tea. A common recommendation for all teas was to 
ensure a fresh preparation and the use of simple instructions 
such that no special education was necessary. The group did 
not recommend teas as an intervention in immune-sup-
pressed patients (HSCT, leucocytes less than 1500 per µL). 
Due to the acquisition of the tea, the cooking procedure, and 
the necessary fresh preparation, all teas were classified as 
needing time (PFt). Teas were generally recommended to 
be used as mouthwash rather than as ingestions, and—if no 
other procedure was specified—to be used by the patient 3 
times per day at a minimum and 6 times per day at a maxi-
mum to avoid toxic effects.
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Prevention and Treatment of Mucositis
From experts’ opinion, the following nursing procedures 
were classified as high effective (CE4) for prevention of 
oral mucositis: sea buckthorn pulp oil, marshmallow 
root tea, OraLife gel and mouthwash (AgainLife), and 
propolis. Concerning the feasibility, OraLife and sea 
buckthorn pulp oil are expensive (40€ to 60€ per month), 
and the marshmallow root tea needs time to prepare 
(roots should be allowed to soak for 2 hours). 
Applications with a relatively effective CE3 (based on 
the experts’ opinion) were the sunflower or sesame oil 
extraction and the flaxseed solution. The experts’ insti-
tutions recommend these relatively low-cost and easy 
handling methods (PE1), although the flaxseed solution 
needs time for preparation (PFt).
Sea buckthorn pulp oil, OraLife gel, and propolis were 
also classified as high effective (CE4) for the treatment of 
oral mucositis. Additionally, mare milk, Helago chamomile 
oil (Helago-Pharma), and Saliva Natura oral spray (Medac 
GmbH) were also considered effective in the treatment of 
oral mucositis based on clinical experience as high effective 
(CE4). All were classified as easy to handle, but mare milk 
was classified as expensive (PFc). Ice cubes of pureed pine-
apple, flaxseed solution, tea ice cubes (marshmallow root), 
and Kamistad gel (STADA) were also recommended for 
treatment and rated as relatively effective (CE3).
Results of the Literature Search
The literature search revealed a total of 329 publications 
(128 from PubMed, 192 from EMBASE, 8 from Cochrane 
Library, and 1 from national and international medical 
guidelines by manual search1,4; Figure 1); 18 duplicates 
were removed. Of those, 284 publications were excluded 
after title and abstract screening because they were not 
Table 1. Expert Judgements for the Different Nursing Applications Based on Expert Consensus.
Safety
Clinical experience  






Notes in case of 
immunesuppression Prevention Therapy
Sea buckthorn pulp oil S CE4 (1/6) CE4 (4/6) ET 1 PFc (stained) Use unclear
Marshmallow root tea Also for 
xerostomia
S CE4 (1/6) — ET 1 PFt  
OraLife gel and mouthwash S CE4 (1/6) CE4 (1/6) ET 1 PFc  
Propolis S CE4 (1/6) CE4 (1/6) ET 1 PF Use unclear
Mare milk S — CE4 (1/6) ET 0 PFc Operator should 
decide
Helagochamomile oil S — CE4 (1/6) ET 0 PF Use unclear
Saliva Natura oral spray For treating 
xerostomia
S — CE4 (1/6) ET 0 PF  
Oil extraction with sunflower or 
sesame oil
S CE3 (4/6) ET 1 PF Caveat: 
contaminations
Ice cubes of pureed pineapple S CE3 (4/6) ET 1 PF Use unclear
Flaxseed solution S CE3 (3/6) CE3 (2/6) ET 1 PFt Only fresh
Marshmallow root tea ice cubes S CE3 (2/6) ET 1 PF  
Kamistad STADA S CE3 (1/6) ET 0 PF  
Water ice cubes S CE2 (3/6)a CE2 (3/6) ET 1 PF  
Chamomile flower tea for 
excessive mucus production
S CE2 (2/6) ET 1 PFt  
Calendula flower tea For treating 
xerostomia
S CE2 (2/6) ET 1 PFt  
Repha-Os oral spray S CE2 (2/6) ET 1 PF  
Traumeel ampules S CE2 (1/6) CE2 (1/6) ET 1 PFc Hygienic instructions
Sage tea No use in case 
of xerostomia
S CE1 (5/6) ET 1 PFt  
Almond-lemon oil S CE1 (1/6) ET 1 PF No use
Abbreviations: CE, clinical experience: numerical 0 to 5 scale with 0 = no effect and 5 = maximum effect; ET, effort of training: education 
requirements in addition to a nursing grade; 0 = no additional instructions or education needed; 1 = instructions needed; PF, practical feasibility: PFc, 
feasibility limited due to high costs (>30€ per month); PFt, feasibility limited due to time requirements (more than 15 minutes); S, safe.
aOnly for 5-fluorouracil-bolus application.
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related with oral mucositis (n = 172), not RCTs, meta-anal-
yses, or medical guidelines (n = 89), not human studies (n = 
8), and pediatric patients (n = 5), duplicates (n = 7), or the 
full text could not be accessed (n = 9). Another 9 studies 
Table 2. Active Ingredients of Medical Agents.
OraLife gel and mouthwash Stearic acid, azelaic acid, palmidrol, Aloe vera leaves extract, sodium fluoride, olaflur, chlorhexidine 
digluconate, oleic acid, xylitol, 9,11-linoleic acid, palmitic acid
Saliva Natura oral spray for 
treating xerostomia
Natural extract of the plant yerba santa (Eriodictyon crassifolium, “holy herb”)
Kamistad STADA Lidocaine hydrochloride and extracts of chamomile flowers
Repha-Os oral spray Stevia leaves extract, eucalyptus oil, peppermint oil, aniseed oil, tormentil root extract, myrrh extract, 
ratanhia root extract, clove oil, levomenthol
Traumeel Achillea millefolium (yarrow), Aconitum napellus (iron hat), Arnica montana (mountain charter), Atropa 
belladonna (belladonna), Bellis perennis (daisies), Calendula officinalis (marigold), Echinacea purpurea 
(purple sun hat), Echinacea (narrow-leaved sun hat)
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Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
Adapted from: Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: 
the PRISMA Statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed1000097
were excluded after reading the full text because they were 
duplicates (n = 1), used multiple interventions (n = 3), were 
not published in English language (n = 1), were not RCT, 
meta-analyses, or medical guidelines (n = 2), were 
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systematic reviews of more than 1 intervention (n = 1), or 
were a collection of different topics (n = 1).
After reviewing the findings, 12 trials, for chamomile 
(n = 3), Calendula (n = 1), sage (n = 1), propolis (n = 2), 
and sucking ice cubes (cryotherapy; n = 5), were included. 
None of the included studies reported any serious adverse 
events, or there was lack of safety data from publications.
In detail for chamomile, 3 RCTs were found that investi-
gated various chamomile preparations for the prophylaxis 
of RT-, CT-, or HSCT-induced mucositis with contradictory 
results (Table 3).9-11 Two guidelines1,4 have evaluated cham-
omile for the prevention of mucositis. However, there was 
no recommendation for or against the use of chamomile 
preparations for the prophylaxis of oral mucositis, as the 
evidence from clinical studies was judged as insufficient.
For sage leaves, 1 RCT (n = 60) showed a significantly 
lower incidence of oral grade 1 chemotherapy-induced 
mucositis with a hydrosol of sage tea, thyme, and pepper-
mint in addition to basic oral care. This intervention has a 
prophylactic effect on mucositis in comparison to controls 
with basic oral care alone12 (Table 3).
For Calendula, the randomized, placebo-controlled 
study of Babaee et al13 showed that the addition of an extract 
of Calendula flowers as mouthwash to an aqueous gel sig-
nificantly reduced the level of radiogenic mucositis com-
pared with the application of the gel alone during RT or 
radiochemotherapy of head and neck tumors (Table 3).
Six RCTs investigated whether oral use of propolis had 
prophylactic efficacy on oral mucositis compared with pla-
cebo or standard treatment. A meta-analysis of Kuo et al14 
analyzed 5 of those trials, 4 with chemotherapy-induced 
and 1 with RT-associated mucositis, with a total of 209 par-
ticipants. The incidence of severe oral mucositis was sig-
nificantly lower in the propolis group than in the control 
group. No side effects were reported. Furthermore, the new 
randomized study of Piredda et al15 with 60 breast cancer 
patients concluded that propolis plus bicarbonate was safe, 
well tolerated, and promisingly effective in the prevention 
of oral mucositis in patients with breast cancer (Table 3).
According to the literature, 16 RCTs investigated whether 
oral use of water ice cubes had prophylactic efficacy on oral 
mucositis compared with no or standard treatment. The 
results of 7 of these studies16-22 demonstrate the efficacy of 
oral cryotherapy for the prophylaxis of 5-fluorouracil (5-FU; 
bolus administration mostly combined with leucovorin)–
induced oral mucositis. Furthermore, 7 studies confirmed 
the efficacy of oral cryotherapy for the prophylaxis of oral 
mucositis due to high-dose CT with melphalan for autolo-
gous SCT23-26 or other myeloablative regimens prior to allo-
geneic SCT.27-29 The results of the study by Gori et al30 
showed no effects of oral cryotherapy for the prophylaxis of 
oral mucositis induced by low-dose methotrexate given for 
graft versus host disease prophylaxis after allogeneic stem 
cell transplantation. The results of the study by Kakoei et al31 
give an indication of the efficacy of oral cryotherapy for the 
prophylaxis of radiogenic oral mucositis. All mentioned 
studies were presented with details in the review of Peterson 
et al32 and/or the Cochrane Review by Riley et al.2 The 
German S3 guideline Supportive Therapy in Oncology4 
partly refers to the MASCC guideline for Oral Mucositis1 
and highlights (1) a recommendation that 30-minute oral ice 
chewing should be used for the prophylaxis of oral mucositis 
in patients receiving bolus 5-FU chemotherapy, (2) a recom-
mendation that oral sucking of ice cubes can be used for the 
prophylaxis of oral mucositis in patients with HSCT with 
high-dose melphalan (with or without whole-body irradia-
tion), and (3) no recommendation for or against the use of 
oral cryotherapy for the prophylaxis or therapy of oral radio-
genic mucositis, as there is insufficient evidence. The results 
of the study by Lu et al33 showed that oral cryotherapy inter-
vention during the whole course or during the second half of 
the course of the cytotoxic BUCY regimen (including cyta-
rabine, busulfan, and cyclophosphamide) in allogeneic 
HSCT patients was associated with a lower incidence and 
shorter duration of severe mucositis (≥grade 3). On the 
other hand, the highest incidence of severe mucositis was 
observed in regular oral cryotherapy group (twice a day). 
Moreover, cryotherapy should not be applied as a part of 
daily routine care because it could damage the oral mucosa. 
The results of the study by Park and Lee34 indicated that 
cryotherapy was effective for solid cancer patients who 
receive 5-FU or cisplatin anticancer drugs.
Comparing Consensus-Based Results With 
Literature Search
The treatments listed in the consensus process shows that 7 
applications were classified as high effective (CE4), and 5 
applications were classified relatively effective (CE3) for 
prevention or treatment of oral mucositis.
In the literature research process, of the 19 applications, 
only 5 applications matched our inclusion criteria of sys-
tematic literature search. These 5 applications were propo-
lis, cryotherapy/water ice cubes, chamomile, Calendula, 
and sage tea. The evidence level of these applications were 
determined as level 1a for propolis and cryotherapy, level 
1b for chamomile, calendula, and sage tea (Table 4).
Discussion
Cancer patients have a strong need for integrative, nondrug, 
self-management, and self-efficacy enhancing applications 
for alleviating symptoms.3,35 In conventional and even more 
in integrative oncology, nurses often support patients with 
oral mucositis with individual recommendations during their 
inpatient stay and provide advice to outpatients.1,21,35 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 Integrative Cancer Therapies 
based on the experiences of therapists and institutions, or on 
naturopathic knowledge in general. Furthermore, research is 
rare, the evidence is inconsistent, and most patients with can-
cer therapy–associated oral mucositis receive a broad range 
of different mouthwashes of varying quality and efficacy.2,5,9 
For the first time, in the setting of a symposium, nurses, phy-
sicians, and a psychologist in German-speaking countries 
with naturopathic and/or anthroposophical medicine back-
grounds were brought together to evaluate the usefulness of 
nursing procedures for oral mucositis from clinical experi-
ence and to compare these with evidence from the literature. 
Nineteen nursing interventions were evaluated in a consen-
sus process from an expert panel and whether interventions 
are safe and/or easy to apply. Most of the applications were 
high effective, in the experts’ opinion (Table 1).
In the experts’ opinion, 7 procedures were classified as 
high effective (CE4) for prevention or treatment of oral 
mucositis. Except for sea buckthorn pulp oil, all interven-
tions were only applied in one institution each, supporting 
the known broad range of different applications in hospitals 
and institutions to prevent or treat oral mucositis. This fact 
also limits the presented results. More institutions have 
expertise in and recommend 5 further applications, classi-
fied as relatively effective (CE3), all of which are relatively 
low-cost methods. However, the flaxseed solution and the 
marshmallow root tea need time and special requirements 
for preparation and are, therefore, not easily applicable in 
hospitals. The methods such as sunflower or sesame oil 
extraction, sea buckthorn pulp oil, and the industrial prod-
uct OraLife were judged as so promising by the experts that 
hospitals without previous experience decided to apply 
these methods from then on.
The first limitation of the consensus process was the 
small number of participants and institutions. The second 
limitation is that this does not seem to be a genuine con-
sensus process but in the majority of cases more a single 
expert opinion. Most listed interventions were often 
applied only by one center. Despite the high expertise in 
this panel, important therapy approaches may still be lack-
ing. Furthermore, the efficacy was estimated subjectively 
and depended on the experience of 1 or 2 practitioners.
Comparing the experience-based results with the litera-
ture-based evidence, there was a noted mismatch. No inter-
ventional studies existed for 5 of the 7 applications estimated 
as high effective (CE4). Controlled trials were only found for 
oral propolis and chamomile interventions. Although the evi-
dence for chamomile in homogeneous preparations is low and 
inconsistent, the studies for propolis are predominantly of 
high quality and had a positive outcome for efficacy.9-11,14,15
Procedures with the sunflower or sesame oil extraction, 
flaxseed solution, Kamistad, and ice cubes of marshmallow 
root tea or pureed pineapple were rated as relatively effec-
tive (CE3). In addition to the aforementioned chamomile 
preparation studies, only studies with pure ice cryotherapy 
Table 4. Comparing Consensus-Based Results With Literature Search.
Treatments listed in the consensus process
Clinical experience 
as evaluated
Results of systematic 
literature search
OCEBM level of 
evidence8
Propolis CE4 Meta-analysis Level 1a
Sea buckthorn pulp oil No studies were found matching our inclusion 
criteria in the systematic literature search.Marshmallow root tea
OraLife gel and mouthwash
Mare milk
Helago chamomile oil
Saliva Natura oral spray
Oil extraction with sunflower or sesame oil CE3 No studies were found matching our inclusion 
criteria in the systematic literature search.Ice cubes of pureed pineapple
Flaxseed solution
Marshmallow root tea ice cubes
Kamistad STADA
Cryotherapy/water ice cubes CE2 Meta-analysis and RCT Level 1a
Chamomile flower tea for excessive mucus production RCT Level 1b
Calendula flower tea RCT Level 1b
Repha-Os oral spray No studies were found matching our inclusion 
criteria in the systematic literature search.Traumeel ampules
Sage tea CE1 RCT Level 1b
Almond-lemon oil No studies were found matching our inclusion 
criteria in the systematic literature search.
Abbreviations: CE, clinical experience: numerical 0 to 5 scale with 0 = no effect and 5 = maximum effect; OECBM Level of Studies, Oxford Centre 
for Evidence-based Medicine; Levels of Evidence, Definition of the level of evidence are as follows: Level 1a: systematic reviews (with homogeneity*) of 
RCTs, Level 1b: individual RCT; RCT, randomized controlled trial.
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exist.2,32 However, the guidelines support cryotherapy only 
for the prophylaxis of oral mucositis in patients receiving 
bolus 5-FU chemotherapy and in patients with HSCT with 
high-dose melphalan.1,4 There is no recommendation for 
RT-induced mucositis due to insufficient evidence. Oral 
sucking of ice cubes is to be considered as counterproduc-
tive in cancer-treating situations in patients with head and 
neck cancer, especially with cancer in the mouth or oro-
pharynx. Altogether, published evidence for the strategies 
that were recommended as moderately to highly effective 
by the expert panel only exists for propolis and ice cubes.
Despite this growing evidence base on supportive nurs-
ing application, further research in this field is necessary. 
High expenditure associated with high costs might aggra-
vate the implementation of such studies in the clinical set-
ting. Therefore, trials on interventions that were judged as 
relatively effective and less time-consuming and costly (eg, 
sunflower or sesame oil extraction) should be initiated first 
to meet patients’ supportive care needs.
Conclusion
Although research is rare, from experts’ opinion, some 
nursing procedures (propolis for grades 2 and 3 mucositis, 
cryotherapy for all grades of chemotherapy-induced muco-
sitis and also as a prophylaxis, oil applications and indus-
trial herb preparations for prevention of mucositis) are 
promising for improving oral mucositis in cancer patients. 
It is, however, not yet possible to conclusively define the 
treatment standards for integrative oncology in the support-
ive treatment of mucositis. Further research is recom-
mended in this area.
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